ID   OGK-P
AC   CVCL_RP36
DR   cancercelllines; CVCL_RP36
DR   Wikidata; Q54931879
RX   PubMed=25365311;
CC   Population: Caucasian.
CC   Doubling time: 23 hours (PubMed=25365311).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys277Tyr (c.830G>A); ClinVar=VCV000185722; Zygosity=Homozygous (PubMed=25365311).
CC   Omics: Deep exome analysis.
CC   Omics: SNP array analysis.
CC   Omics: Transcriptome analysis by microarray.
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
ST   Source(s): PubMed=25365311
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 10,12
ST   D16S539: 9,12
ST   D21S11: 29
ST   D5S818: 10,13
ST   D7S820: 10,13
ST   TH01: 6,10
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C3878; Thyroid gland anaplastic carcinoma
DI   ORDO; Orphanet_142; Anaplastic thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RP35 ! OGK-M
SX   Male
AG   71Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 11
//
RX   PubMed=25365311; DOI=10.1210/jc.2014-2359; PMCID=PMC4318896;
RA   Garg M., Okamoto R., Nagata Y., Kanojia D., Venkatesan S., Anand M.T.,
RA   Braunstein G.D., Said J.W., Doan N.B., Ho Q., Akagi T., Gery S.,
RA   Liu L.-Z., Tan K.-T., Chang W.J., Yang H.H., Ogawa S., Koeffler H.P.;
RT   "Establishment and characterization of novel human primary and
RT   metastatic anaplastic thyroid cancer cell lines and their genomic
RT   evolution over a year as a primagraft.";
RL   J. Clin. Endocrinol. Metab. 100:725-735(2015).
//